Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1252-1255

  Griffith, Brigitte P ^a   Brett Smith, Helena ^d   Kim, Grace ^d   Mellors, John W ^b   Chacko, Thomas M ^d   Garner, Robin B ^d   Cheng, Yung Chi ^d   Alcabes, Philip ^c   Friedland, Gerald ^d  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RNA ANALYSIS; VIREMIA; VIRUS TITRATION;

EID: 0029954858     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1252     Document Type: Article

References (15)

1. Lin TS, Schinazi RF, Prusoff WH. Potent and selective in vitro activity of 3′-deoxythymidine-2′-ene(3′-deoxy-2′,3′- didehydrothymidine) against human immunodeficiency virus. Biochem Pharmacol 1987;36:2713-8.
2. Dudley MN, Graham KK, Kaul S, et al. Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex. J Infect Dis 1992:166:480-5.
3. Lin PF, Samanta H, Rose RE, et al. Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. J Infect Dis 1994;170:1157-64.
4. Browne MJ, Mayer KH, Chafee SBD, et al. 2′,3′-didehydro-3′-deoxy-thymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J Infect Dis 1993;167:21-9.
5. Murray HW, Squires KE, Weiss W, et al. Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. J Infect Dis 1995;171(suppl 2):S123-30.
6. Petersen EA, Ramírez-Ronda CH, Hardy WD, et al. Dose-related activity of stavudine in patients infected with human immunodeficiency virus. J Infect Dis 1995;171(suppl 2):S131-9.
7. Anderson RE, Mohanty S, Wilber JC, Dailey PJ. Measurement of HIV antiviral activity by direct HIV RNA quantitation in frozen peripheral blood mononuclear cells (PBMCs) using branched DNA (bDNA) assay [abstract PB 0828]. In: Program and abstracts: X International Conference on AIDS/International Conference on STD (Yokohama). Tokyo: Japanese Foundation for AIDS Prevention, 1994.
8. Dunkle LM, Pavia A, Messina ME, Cross AP, BMS-019 Study Group. Stavudine (d4T) vs zidovudine (ZDV) for the treatment of HIV-infected patients with CD4 counts of 50-500 cells/mm3 following at least 6 months zidovudine. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy meeting (Orlando, FL). Washington, DC: American Society for Microbiology, 1994.
9. US Department of Health and Human Services. ACTG virology manual for HIV laboratories. Rockville, MD: Health Resources and Services Administration, 1994; NIH publication 94-3828.
10. Ho DD, Mougdil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
11. Imai H, Yamada O, Morita S, Suehiro S, Kurimura T. Detection of HIV-1 RNA in heparinized plasma of HIV-1 seropositive individuals. J Virol Methods 1992;36:181-4.
12. Mullis K, Faloona F, Scharf S, et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol 1986;51 (part l):263-73.
13. Sommadossi JP. Comparison of metabolism and in vitro antiviral activity of stavudine versus other 2′,3′-dideoxynucleoside analogues. J Infect Dis 1995;171 (suppl 2):S88-92.
14. Riddler SA, Anderson RE, Mellors JW. Antiretroviral activity of stavudine (2′,3′didehydro-3′deoxythymidine, d4T). Antiviral Res 1995;27:189-203.
15. Holodniy M, Mole L, Yen-Lieberman B, et al. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in Vacutainer CPT, Vacutainer PPT, and standard Vacutainer tubes. J Clin Microbiol 1995;33:1562-6.